These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

186 related articles for article (PubMed ID: 7551924)

  • 1. New drugs in non-small cell lung cancer. An overview.
    Giaccone G
    Lung Cancer; 1995 Apr; 12 Suppl 1():S155-62. PubMed ID: 7551924
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Promising new agents in the treatment of non-small cell lung cancer.
    Edelman MJ; Gandara DR
    Cancer Chemother Pharmacol; 1996; 37(5):385-93. PubMed ID: 8599859
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Clinical and cost effectiveness of paclitaxel, docetaxel, gemcitabine, and vinorelbine in non-small cell lung cancer: a systematic review.
    Clegg A; Scott DA; Hewitson P; Sidhu M; Waugh N
    Thorax; 2002 Jan; 57(1):20-8. PubMed ID: 11809985
    [TBL] [Abstract][Full Text] [Related]  

  • 4. New chemotherapeutic agents for non-small cell lung cancer.
    Miller VA; Rigas JR; Grant SC; Pisters KM; Kris MG
    Chest; 1995 Jun; 107(6 Suppl):306S-311S. PubMed ID: 7781411
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rationale for non-platinum chemotherapy in advanced NSCLC.
    Murren JR
    Oncology (Williston Park); 2001 Jul; 15(7 Suppl 8):29-34. PubMed ID: 11497229
    [TBL] [Abstract][Full Text] [Related]  

  • 6. New drugs in the treatment of non-small cell lung cancer.
    Steward WP; Dunlop DJ
    Ann Oncol; 1995; 6 Suppl 1():49-54. PubMed ID: 8695545
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [New wave of chemotherapeutic agents: update in pulmonary oncology].
    Sculier JP
    Rev Mal Respir; 1997 Apr; 14(2):154-6. PubMed ID: 9198842
    [No Abstract]   [Full Text] [Related]  

  • 8. Second-line chemotherapy for recurrent non-small cell lung cancer: do new agents make a difference?
    Ferrigno D; Buccheri G
    Lung Cancer; 2000 Aug; 29(2):91-104. PubMed ID: 10963840
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [New cytostatics in the therapy of non-small cell bronchial carcinoma].
    Serke M; Schönfeld N; Loddenkemper R
    Pneumologie; 1998 Jun; 52(6):333-7. PubMed ID: 9715648
    [No Abstract]   [Full Text] [Related]  

  • 10. New chemotherapeutic agents for the treatment of non-small cell lung cancer: the Japanese experience.
    Saijo N
    Chest; 1998 Jan; 113(1 Suppl):17S-23S. PubMed ID: 9438685
    [TBL] [Abstract][Full Text] [Related]  

  • 11. New drug for therapy of non-small cell lung cancer.
    Klastersky J
    Lung Cancer; 1994 Nov; 11 Suppl 3():S139-49. PubMed ID: 7704506
    [No Abstract]   [Full Text] [Related]  

  • 12. [Recent results of anticancer drugs acting on microtubules--navelbine, taxol and taxotere for the treatment of lung cancer].
    Kawahara M; Furuse K
    Gan To Kagaku Ryoho; 1992 Nov; 19(13):2150-6. PubMed ID: 1359840
    [No Abstract]   [Full Text] [Related]  

  • 13. [New promising anticancer drugs for lung cancer].
    Ariyoshi Y; Sugiura T
    Gan To Kagaku Ryoho; 1994 Nov; 21(15):2578-84. PubMed ID: 7979416
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Vinorelbine in the treatment of non-small-cell lung cancer and breast cancer].
    Kubota K
    Gan To Kagaku Ryoho; 2000 Jul; 27(8):1301-6. PubMed ID: 10945030
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The dilemma of first-line chemotherapy in advanced non-small-cell lung cancer: are third-generation drugs all the same?].
    Grossi F; de Marinis F; Frontini L; Gridelli C
    Tumori; 2008; 94(3):5-14. PubMed ID: 18705422
    [No Abstract]   [Full Text] [Related]  

  • 16. [Lung cancer].
    Furuse K
    Gan To Kagaku Ryoho; 1997 Oct; 24(13):1917-24. PubMed ID: 9350236
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recent advances in managing non-small-cell lung cancer: 4. Chemotherapy of metastatic cancer.
    Clarke SJ; Boyer MJ
    Med J Aust; 1997 Jun; 166(S1):S14-6. PubMed ID: 9201199
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Phase II and III studies with new drugs for non-small cell lung cancer: a systematic review of the literature with a methodology quality assessment.
    Meert AP; Berghmans T; Branle F; Lemaître F; Mascaux C; Rubesova E; Vermylen P; Paesmans M; Sculier JP
    Anticancer Res; 1999; 19(5C):4379-90. PubMed ID: 10650780
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of granulocyte growth factors in the treatment of non small cell lung cancer.
    Gridelli C; Barzelloni ML; Barletta E; Guida C; Gatani T; Fiore F; Scognamiglio F
    Clin Ter; 1999; 150(3):231-4. PubMed ID: 10528437
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Docetaxel (Taxotere) and vinorelbine in the treatment of non-small cell lung cancer.
    Georgoulias V; Kourousis C; Androulakis N; Kakolyris S; Papadakis E; Bouros D; Apostolopoulou F; Georgopoulou T; Agelidou M; Souglakos J; Halkiadakis G; Hatzidaki D
    Semin Oncol; 1997 Aug; 24(4 Suppl 14):S14-9-S14-14. PubMed ID: 9335517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.